Sign in →

Test Code CXGCCO Neisseria gonorrhoeae and Chlamydia trachomatis by PCR, Non-Genital

Additional Codes

Epic EAP
LAB2201 Neisseria gonorrhoeae and Chlamydia trachomatis by PCR, Non-Genital 

Specimen Requirements

Preferred Collection Container: 

Roche Cobas PCR Media

 

Also Acceptable Collection Container: 

Universal Transport Media
UTM/VTM
Copan ESwab
Aptima swab

 

Collection Information: 

1. Remove one swab from the packaging.
2. Rotate the swab in the specimen site.
3. Immediately place the swab into the transport medium. Break the shaft of the swab, leaving the remaining swab in the transport medium. Make sure the cap is tightly secured to the tube.

 

Transport Information: 

Refrigerated recommended; frozen acceptable; ambient- do not reject

 

Remarks: 

Gross presence of blood may interfere with test performance.
Collection using carbomer-containing products may generate invalid or false negative results.
STI Sample Collection Guidance - Carbomer-free and Carbomer-containing product list (2023)

 

Unacceptable Conditions: 

Specimens NOT collected and placed in Universal viral transport medium or cobas® PCR media or Eswab.

Stability

Refrigerated Stability: 

Universal Viral Transport Media: 7 days
Copan Eswab: 7 days
cobas PCR Media: 12 months
Aptima Swab: 7 days

 

Frozen Stability: 

Universal Viral Transport Media: 30 days
Copan Eswab: 30 days

 

Ambient Stability: 

cobas PCR Media: 12 months

CPT

87801

Methodology

Polymerase Chain Reaction

Performance

Mon-Fri

 

Analytical Time: 

Within 7 days of receipt

 

Testing Laboratory: 

Pathology Laboratory

 

Laboratory Section: 

Microbiology

Interpretive Data

This assay should not be used to assess therapeutic success or failure for persons treated with the CDC recommended or alternative regimens, since nucleic acids from these organisms may persist for 3 weeks or more following antimicrobial therapy. If a test-of-cure is requested, a Chlamydia culture (EPIC LAB 2166), should be requested. This test is appropriate for retesting at three months or longer post antimicrobial therapy.